CN104547292A - Compound medicine for treating chronic rhinitis - Google Patents
Compound medicine for treating chronic rhinitis Download PDFInfo
- Publication number
- CN104547292A CN104547292A CN201410779971.0A CN201410779971A CN104547292A CN 104547292 A CN104547292 A CN 104547292A CN 201410779971 A CN201410779971 A CN 201410779971A CN 104547292 A CN104547292 A CN 104547292A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicine
- herba
- flos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a compound medicine for treating chronic rhinitis, prepared from pure Chinese herbal medicines, and belongs to the technical field of traditional Chinese medicines. The medicine is prepared from divaricate saposhnikovia root, cocklebur fruit, radix angelicae, magnolia flower, cordate houttuynia, scutellaria baicalensis, angelica, salvia miltiorrhiza, dandelion, dried orange peel, root of common peony, asarum, gypsum, radices ligustici sinensis, astragalus membranaceus, liquorice root, peppermint, fineleaf schizonepeta herb, semen plantaginis, honeysuckle, safflower, ephedra, almond, chastetree fruit, platycodon grandiflorum, wild chrysanthemum flower and rhizoma anemones altaicae according to certain proportions. The medicine disclosed by the invention is prepared after being adjusted on the basis of basic theories of traditional Chinese medicines, modern pharmacology researches of traditional Chinese medicines and long-term clinical application; the medicine has functions of clearing the lung for resuscitation, removing necrotic tissue and promoting granulation, and clearing away heat and toxic materials; and the medicine can be used for effectively treating various chronic rhinitis, so that the medicine is a good chronic rhinitis treating medicine suitable for popularization and application.
Description
Technical field
The present invention relates to a kind of medicine of pure herbal raw material preparation, a kind of compound medicine for the treatment of chronic rhinitis, belongs to technical field of Chinese medicine specifically.
Background technology
Chronic rhinitis is a kind of common many property morbidities clinically, and main manifestations is that headache, weak, hypomnesis, vexed anorexia, lethargy, nervous, uncomfortable in chest, pessimistic, spirit depressing are down to causing the symptoms such as neurasthenia.Cause nasal membrane congestion and edema during rhinitis outbreak, nasal sinuses, sieve Dou Xiangji infection inflammation, severe patient also can cause tonsil inflammation, congestion and edema, laryngopharynx swelling and pain, oral ulcer etc., brings painful and inconvenient greatly to the work of patient and life.The primary disease cause of disease is complicated, and the course of disease is long, and touching difficulty more.For a long time, western medical treatment rests in Rapid reversal symptom for the treatment of chronic rhinitis always, main employing topical application nasal drop, spray, electric coagulation, cryotherapy, operative treatment etc., these class methods can only temporarily change nasal airflow situation, and to diminishing inflammation not too large effect, thoroughly cannot deal with problems, once stop using, will again show effect.In the traditional Chinese medical science, chronic rhinitis belongs to the category such as Chinese medicine " nasal sinusitis ", " sinusitis with purulent discharge ", " allergic rhinitis ", also has now more Chinese medicine formula to be used for the treatment of chronic rhinitis, but most of curative effect is not remarkable, temporarily can only play the effect of alleviation, cure the symptoms, not the disease.
Summary of the invention
For solving prior art Problems existing, the invention provides a kind of compound medicine for the treatment of chronic rhinitis.This medicine is made up of Chinese medicine, and compatibility is reasonable, evident in efficacy, safe without toxic side effect.
The present invention is by the following technical solutions:
A kind of compound medicine for the treatment of chronic rhinitis, it is characterized in that, it is formulated by the crude drug of following weight portion: Radix Saposhnikoviae 6-12 part, Fructus Xanthii 12-14 part, Radix Angelicae Dahuricae 6-12 part, Flos Magnoliae 3-10 part, Herba Houttuyniae 12-16 part, Radix Scutellariae 10-14 part, Radix Angelicae Sinensis 12-14 part, Radix Salviae Miltiorrhizae 20-26 part, Herba Taraxaci 12-16 part, Pericarpium Citri Reticulatae 12-16 part, Radix Paeoniae Rubra 10-14 part, Herba Asari 3-6 part, Gypsum Fibrosum 15-20 part, Rhizoma Ligustici 10-14 part, Radix Astragali 14-18 part, Radix Glycyrrhizae 10-14 part, Herba Menthae 10-14 part, Herba Schizonepetae 8-12 part, Semen Plantaginis 12-16 part, Flos Lonicerae 12-16 part, Flos Carthami 8-12 part, Herba Ephedrae 4-8 part, Semen Armeniacae Amarum 10-14 part, Fructus Viticis 12-14 part, Radix Platycodonis 8-12 part, Flos Chrysanthemi Indici 10-12 part, capital Rhizoma Acori Graminei 10-14 part.
Preferably, a kind of compound medicine for the treatment of chronic rhinitis, it is formulated by the crude drug of following weight portion: Radix Saposhnikoviae 8 parts, Fructus Xanthii 13 parts, the Radix Angelicae Dahuricae 10 parts, Flos Magnoliae 6 parts, Herba Houttuyniae 15 parts, Radix Scutellariae 12 parts, Radix Angelicae Sinensis 13 parts, Radix Salviae Miltiorrhizae 24 parts, Herba Taraxaci 14 parts, Pericarpium Citri Reticulatae 14 parts, Radix Paeoniae Rubra 13 parts, Herba Asari 4 parts, 17 parts, Gypsum Fibrosum, Rhizoma Ligustici 13 parts, the Radix Astragali 16 parts, 12 parts, Radix Glycyrrhizae, Herba Menthae 12 parts, Herba Schizonepetae 10 parts, Semen Plantaginis 14 parts, Flos Lonicerae 14 parts, 10 parts, Flos Carthami, 6 parts, Herba Ephedrae, 12 parts, Semen Armeniacae Amarum, Fructus Viticis 13 parts, Radix Platycodonis 10 parts, Flos Chrysanthemi Indici 11 parts, capital Rhizoma Acori Graminei 12 parts.
The preparation method of medicine of the present invention is as follows: first by classification of drug, and Gypsum Fibrosum is first descend medicine; Herba Ephedrae, Herba Menthae, Flos Carthami, Flos Chrysanthemi Indici, Herba Asari, Flos Lonicerae, Flos Magnoliae are rear lower medicine; Other are lower medicine in being.
(1) take rear lower medicine by formula ratio, add the water soaking 40 minutes of 9 times of weight wherein; Take the Gypsum Fibrosum of formula ratio and grind into powder, add the soak by water of about 500ml afterwards to boiling 15 minutes;
(2) in above-mentioned Gypsum Fibrosum decoction liquor, to add in formula ratio lower medicine and 5 times to the water of its weight, decoct to boiling 15 minutes;
(3) rear lower medicine obtained in step (1) is added in the decoction liquor of step (2), continue decocting and filter to obtain first-time filtrate 200ml to boiling after 30 minutes;
(4) water adding 5 times of weight in the medicinal residues after filtration continues to decoct to boiling 35 minutes, filters to obtain secondary filtrate 200ml;
(5) first-time filtrate and the merging of secondary filtrate are left standstill, get supernatant and be heated to seethe with excitement and get final product.
Usage of the present invention and consumption are: decocting is oral, potion on the one, sooner or later within 1 hour after meal, respectively take 200ml, warm water delivery service.Within 5 days, be 1 course for the treatment of, general 2-5 can cure the course for the treatment of.
Medicine of the present invention is worked out according to after Basic Theories of Chinese Medicine, Chinese medicine modern pharmacological research, long-term clinical application adjustment, it is evident in efficacy, cure rate is high, and therapeutic domain is extensive, all has good effect to chronic rhinitis, chronic pharyngitis, laryngitis, tonsillitis, oral ulcer.
The invention has the beneficial effects as follows: compatibility of drugs of the present invention is reasonable, and evident in efficacy, cure rate is high, safe without toxic side effect, and cost is low, is convenient to promote the use of.This medicine has that suitable lung is sensible, effect of removing the necrotic tissue and promoting granulation, heat-clearing and toxic substances removing, can effectively treat all kinds of chronic rhinitis, eliminates the serious commercial burden that patient brings because of expensive expense needed for operative treatment.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention is described in further detail.
Embodiment 1
Treat a compound medicine for chronic rhinitis, it is formulated by the crude drug of following weight: Radix Saposhnikoviae 6g, Fructus Xanthii 12g, Radix Angelicae Dahuricae 6g, Flos Magnoliae 3g, Herba Houttuyniae 12g, Radix Scutellariae 10g, Radix Angelicae Sinensis 12g, Radix Salviae Miltiorrhizae 20g, Herba Taraxaci 12g, Pericarpium Citri Reticulatae 12g, Radix Paeoniae Rubra 10g, Herba Asari 3g, Gypsum Fibrosum 15g, Rhizoma Ligustici 10g, Radix Astragali 14g, Radix Glycyrrhizae 10g, Herba Menthae 10g, Herba Schizonepetae 8g, Semen Plantaginis 12g, Flos Lonicerae 12g, Flos Carthami 8g, Herba Ephedrae 4g, Semen Armeniacae Amarum 10g, Fructus Viticis 12g, Radix Platycodonis 8g, Flos Chrysanthemi Indici 10g, capital Rhizoma Acori Graminei 10g.
The preparation method of medicine of the present invention is as follows: first by classification of drug, and Gypsum Fibrosum is first descend medicine; Herba Ephedrae, Herba Menthae, Flos Carthami, Flos Chrysanthemi Indici, Herba Asari, Flos Lonicerae, Flos Magnoliae are rear lower medicine; Other are lower medicine in being.
(1) take rear lower medicine by formula ratio, add the water soaking 40 minutes of 9 times of weight wherein; Take the Gypsum Fibrosum of formula ratio and grind into powder, add the soak by water of about 500ml afterwards to boiling 15 minutes;
(2) in above-mentioned medicinal liquid, to add in formula ratio lower medicine and 5 times to the water of its weight, decoct to boiling 15 minutes;
(3) rear lower medicine obtained in step (1) is added in the decoction liquor of step (2), continue decocting and filter to obtain first-time filtrate 200ml to boiling after 30 minutes;
(4) water adding 5 times of weight in the medicinal residues after filtration continues to decoct to boiling 35 minutes, filters to obtain secondary filtrate 200ml;
(5) first-time filtrate and the merging of secondary filtrate are left standstill, get supernatant and be heated to seethe with excitement and get final product.
Embodiment 2
Treat a compound medicine for chronic rhinitis, it is formulated by the crude drug of following weight portion: Radix Saposhnikoviae 8 parts, Fructus Xanthii 13 parts, the Radix Angelicae Dahuricae 10 parts, Flos Magnoliae 6 parts, Herba Houttuyniae 15 parts, Radix Scutellariae 12 parts, Radix Angelicae Sinensis 13 parts, Radix Salviae Miltiorrhizae 24 parts, Herba Taraxaci 14 parts, Pericarpium Citri Reticulatae 14 parts, Radix Paeoniae Rubra 13 parts, Herba Asari 4 parts, 17 parts, Gypsum Fibrosum, Rhizoma Ligustici 13 parts, the Radix Astragali 16 parts, 12 parts, Radix Glycyrrhizae, Herba Menthae 12 parts, Herba Schizonepetae 10 parts, Semen Plantaginis 14 parts, Flos Lonicerae 14 parts, 10 parts, Flos Carthami, 6 parts, Herba Ephedrae, 12 parts, Semen Armeniacae Amarum, Fructus Viticis 13 parts, Radix Platycodonis 10 parts, Flos Chrysanthemi Indici 11 parts, capital Rhizoma Acori Graminei 12 parts.
Preparation method is with embodiment 1.
Embodiment 3
Treat a compound medicine for chronic rhinitis, it is formulated by the crude drug of following weight portion: Radix Saposhnikoviae 12g, Fructus Xanthii 14g, Radix Angelicae Dahuricae 12g, Flos Magnoliae 10g, Herba Houttuyniae 16g, Radix Scutellariae 14g, Radix Angelicae Sinensis 14g, Radix Salviae Miltiorrhizae 26g, Herba Taraxaci 16g, Pericarpium Citri Reticulatae 16g, Radix Paeoniae Rubra 14g, Herba Asari 6g, Gypsum Fibrosum 20g, Rhizoma Ligustici 14g, Radix Astragali 18g, Radix Glycyrrhizae 14g, Herba Menthae 14g, Herba Schizonepetae 12g, Semen Plantaginis 16g, Flos Lonicerae 16g, Flos Carthami 12g, Herba Ephedrae 8g, Semen Armeniacae Amarum 14g, Fructus Viticis 14g, Radix Platycodonis 12g, Flos Chrysanthemi Indici 12g, capital Rhizoma Acori Graminei 14g.
Preparation method is with embodiment 1.
Clinical trial is summed up
1. clinical data: accept patient medical history 110 example at random for medical treatment, wherein male 65 example, women 45 example; Mean age is 29 years old.
2. diagnostic criteria: can make according to Clinical presentation and feature and clarifying a diagnosis.
3. Therapeutic Method: decocting is oral, potion on the one, sooner or later within 1 hour after meal, respectively take 200ml, warm water delivery service, within 5 days, be 1 course for the treatment of, general 2-5 can cure a course for the treatment of.Take the medicine of the embodiment of the present invention 2 during patient treatment, period stops using other any medicines.
4. curative effect determinate standard:
Cure: the clinical sign such as headache, nasal obstruction, rhinophonia, stream dense nasal mucus disappearance after medication.
Effective: after medication, clinical sign major part disappears.
Invalid: after medication, clinical sign is without significant change.
5. therapeutic outcome:
Clinical cure 100 example, accounts for 90.9%; Effective 9 examples, account for 8.2%; Invalid 1 example, accounts for 0.9%; Total effective rate is 99.1%.
Model case
Case 1: Liu, man, 21 years old, student.Within 17 years old, play morbidity, show as intermittent nasal obstruction and owe logical, snivel or mucus nasal mucus, period takes various Chinese medicine and western medicine and is showed no and is clearly better.Use Chinese medicine of the present invention take one the course for the treatment of symptom be clearly better, after continuing to take a course for the treatment of, disease disappears completely, follows up a case by regular visits to and does not recur so far again.
Case 2: Jiang, female, 30 years old, teacher.Within 25 years old, play morbidity, showing as nasal obstruction and owing logical, hyposmia, the few and thickness of nasal mucus.Tossing about in bed many hospitalize several years has no and is clearly better.After give medicine one of the present invention course for the treatment of after symptom obviously alleviate, rear after treatment two recoveries from illness courses for the treatment of, follow up a case by regular visits to and do not recur so far again.
Case 3: Lin, female, 19 years old, student.Within 15 years old, play morbidity, show as nasal obstruction, snivel, sneeze.Check: bilateral hypertrophic inferior turbinate, smooth surface, is diagnosed as " chronic simple rhinitis ", through Duo Jia hospital with to buy Drug therapy 3 years by oneself invalid, use medicine of the present invention after 3 days symptom obviously alleviate, after continuing to take two courses for the treatment of of medicine of the present invention, above transference cure, follows up a case by regular visits to 2 years without recurrence.
Case 4: Xu so-and-so, man, 36 years old, workman.Within 28 years old, play morbidity, show as nasal obstruction, headache, nose clip hypertrophy, congested, secretions increase.Long-term taking various kinds of drug all fails to effect a radical cure.After using a course for the treatment of of medicine of the present invention after being introduced, symptom obviously alleviates, and continue to take 1 course for the treatment of of medicine of the present invention, symptomatology disappears, and follows up a case by regular visits to and does not recur so far.
Case 5: grandson, man, 24 years old, civil servant.Within 20 years old, play morbidity, show as right nose pain, cause right part headache, prosopodynia and toothache, snivel.Be chronic rhinitis through hospital diagnosis, cannot eradicate every year by various Drug therapy 3.After taking a course for the treatment of of medicine of the present invention after being introduced, symptom obviously alleviates, and fully recovers, do not recur so far after continuing to take 2 courses for the treatment of of medicine of the present invention.
Claims (2)
1. treat the compound medicine of chronic rhinitis for one kind, it is characterized in that, it is formulated by the crude drug of following weight portion: Radix Saposhnikoviae 6-12 part, Fructus Xanthii 12-14 part, Radix Angelicae Dahuricae 6-12 part, Flos Magnoliae 3-10 part, Herba Houttuyniae 12-16 part, Radix Scutellariae 10-14 part, Radix Angelicae Sinensis 12-14 part, Radix Salviae Miltiorrhizae 20-26 part, Herba Taraxaci 12-16 part, Pericarpium Citri Reticulatae 12-16 part, Radix Paeoniae Rubra 10-14 part, Herba Asari 3-6 part, Gypsum Fibrosum 15-20 part, Rhizoma Ligustici 10-14 part, Radix Astragali 14-18 part, Radix Glycyrrhizae 10-14 part, Herba Menthae 10-14 part, Herba Schizonepetae 8-12 part, Semen Plantaginis 12-16 part, Flos Lonicerae 12-16 part, Flos Carthami 8-12 part, Herba Ephedrae 4-8 part, Semen Armeniacae Amarum 10-14 part, Fructus Viticis 12-14 part, Radix Platycodonis 8-12 part, Flos Chrysanthemi Indici 10-12 part, capital Rhizoma Acori Graminei 10-14 part.
2. the compound medicine for the treatment of chronic rhinitis according to claim 1, it is characterized in that, it is formulated by the crude drug of following weight portion: Radix Saposhnikoviae 8 parts, Fructus Xanthii 13 parts, the Radix Angelicae Dahuricae 10 parts, Flos Magnoliae 6 parts, Herba Houttuyniae 15 parts, Radix Scutellariae 12 parts, Radix Angelicae Sinensis 13 parts, Radix Salviae Miltiorrhizae 24 parts, Herba Taraxaci 14 parts, Pericarpium Citri Reticulatae 14 parts, Radix Paeoniae Rubra 13 parts, Herba Asari 4 parts, 17 parts, Gypsum Fibrosum, Rhizoma Ligustici 13 parts, the Radix Astragali 16 parts, 12 parts, Radix Glycyrrhizae, Herba Menthae 12 parts, Herba Schizonepetae 10 parts, Semen Plantaginis 14 parts, Flos Lonicerae 14 parts, 10 parts, Flos Carthami, 6 parts, Herba Ephedrae, 12 parts, Semen Armeniacae Amarum, Fructus Viticis 13 parts, Radix Platycodonis 10 parts, Flos Chrysanthemi Indici 11 parts, capital Rhizoma Acori Graminei 12 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410779971.0A CN104547292A (en) | 2014-12-17 | 2014-12-17 | Compound medicine for treating chronic rhinitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410779971.0A CN104547292A (en) | 2014-12-17 | 2014-12-17 | Compound medicine for treating chronic rhinitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104547292A true CN104547292A (en) | 2015-04-29 |
Family
ID=53065063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410779971.0A Pending CN104547292A (en) | 2014-12-17 | 2014-12-17 | Compound medicine for treating chronic rhinitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104547292A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113967193A (en) * | 2020-07-23 | 2022-01-25 | 段育梁 | Water-based spray for treating rhinitis |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101926901A (en) * | 2010-09-01 | 2010-12-29 | 吴业刚 | Chinese medicinal oral liquid for treating chronic rhinitis and sinusitis and preparation method thereof |
| WO2013105693A1 (en) * | 2012-01-12 | 2013-07-18 | 한국교통대학교 산학협력단 | Pharmaceutical composition comprising extract from cortex of oryza sativa l. and hordeum vulgare var. hexastichon as active ingredient |
| CN103948675A (en) * | 2014-05-29 | 2014-07-30 | 张玉芳 | Traditional Chinese medicine for treating chronic rhinitis |
-
2014
- 2014-12-17 CN CN201410779971.0A patent/CN104547292A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101926901A (en) * | 2010-09-01 | 2010-12-29 | 吴业刚 | Chinese medicinal oral liquid for treating chronic rhinitis and sinusitis and preparation method thereof |
| WO2013105693A1 (en) * | 2012-01-12 | 2013-07-18 | 한국교통대학교 산학협력단 | Pharmaceutical composition comprising extract from cortex of oryza sativa l. and hordeum vulgare var. hexastichon as active ingredient |
| CN103948675A (en) * | 2014-05-29 | 2014-07-30 | 张玉芳 | Traditional Chinese medicine for treating chronic rhinitis |
Non-Patent Citations (1)
| Title |
|---|
| 厉金诸: "鼻渊清治疗慢性鼻炎32例", 《新中医》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113967193A (en) * | 2020-07-23 | 2022-01-25 | 段育梁 | Water-based spray for treating rhinitis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103356792B (en) | Chinese medicine composition for treating chronic rhinitis | |
| CN104436125A (en) | Traditional Chinese medicine for treating influenza and preparation method thereof | |
| CN101129862A (en) | Traditional Chinese medicine for treating acute glomerulonephritis | |
| CN104189563A (en) | Traditional Chinese medicine for treating oral ulcer and preparation method thereof | |
| CN102988518A (en) | Traditional Chinese medicine for treating rhinitis | |
| CN104523865A (en) | Medicine for treating breast diseases | |
| CN102178864A (en) | Chinese medicinal oral liquid for treating amygdalitis | |
| CN101129636A (en) | Medicine for treating nasal inflammation | |
| CN103566096A (en) | Traditional Chinese medicine (TCM) oral liquid for treating rhinitis and preparation method thereof | |
| CN103566009A (en) | Traditional Chinese medicine (TCM) composition for treating acute and chronic rhinitis | |
| CN101537141A (en) | Pharmaceutical composition for clearing away heat and toxic material, dispelling wind and eliminating swelling and relieving sore throat to be sensible | |
| CN103356968B (en) | Traditional Chinese medicine composition for treating endometriosis | |
| CN103006872B (en) | Chinese medicinal preparation for treating flu | |
| CN101152494A (en) | Traditional Chinese medicine for treating acute appendicitis | |
| CN105012578A (en) | Traditional Chinese medicine composition for treating allergic rhinitis | |
| CN102614470B (en) | External Chinese herbal composition for treating sequela of apoplexy | |
| CN102225118B (en) | Blood-activating wind-dispelling liquid | |
| CN102100817A (en) | Chinese medicinal preparation for treating infection of upper respiratory tracts | |
| CN104547292A (en) | Compound medicine for treating chronic rhinitis | |
| CN103638360A (en) | Chinese medicine powder for treating nasosinusitis | |
| CN102657709A (en) | A traditional Chinese medicine for treating rhinitis | |
| CN101152483A (en) | Traditional Chinese medicine for treating adult measles in early eruption stage | |
| CN103566028A (en) | Traditional Chinese medicine composition for treating nasosinusitis | |
| CN103877328A (en) | Traditional Chinese medicine for treating acute otitis media suppurative | |
| CN103566219A (en) | Traditional Chinese medicine composition for treating cold |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150429 |